Leonteq Securities AG
Broker-DealerPosition in VRTX — Vertex Pharmaceuticals Inc / Ma
CIK 1535950
ZURICH, V8
Position in VRTX
as of Mar 31, 2026
· filed Apr 27, 2026
Position Value
$1,902,260
-$376,327 QoQ
Shares Held
4,260
-15.2% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.12%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2020
22 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in VRTX Over Time
Shares Held
Position Value (USD)
Derivatives in VRTX
reported options exposure · as of Sep 30, 2024CallValue
$232,540
CallShares
500
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Mar 31, 2026Leonteq Securities AG holds $25,859,639 across 58 Biotechnology names. VRTX ranks #3 (7.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRNA |
Moderna, Inc.
|
302,375 | $15,360,650 | |
| 2 | BNTX |
BioNTech SE
|
26,784 | $2,380,561 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
This page
|
4,260 | $1,902,260 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,212 | $936,439 | |
| 5 | VKTX |
Viking Therapeutics, Inc.
|
22,812 | $742,302 | |
| 6 | IOVA |
Iovance Biotherapeutics, Inc.
|
160,000 | $561,600 | |
| 7 | AXSM |
Axsome Therapeutics, Inc.
|
2,644 | $446,888 | |
| 8 | BEAM |
Beam Therapeutics Inc.
|
12,367 | $294,705 |
All Filings in VRTX
Export CSV
29 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,902,260 | 4,260 | Shares | Sole | 2026-04-27 | |
| 2025-12-31 | $2,278,587 | 5,026 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $2,752,445 | 7,028 | Shares | Sole | 2026-02-17 | |
| 2025-06-30 | $2,027,886 | 4,555 | Shares | Sole | 2026-02-17 | |
| 2025-03-31 | $2,821,652 | 5,820 | Shares | Sole | 2026-02-23 | |
| 2024-12-31 | $2,680,371 | 6,656 | Shares | Sole | 2026-02-23 | |
| 2024-09-30 | $232,540 | 500 | Call | Sole | 2026-03-04 | |
| 2024-09-30 | $2,032,864 | 4,371 | Shares | Sole | 2026-03-04 | |
| 2024-06-30 | $234,360 | 500 | Call | Sole | 2026-03-04 | |
| 2024-06-30 | $2,640,299 | 5,633 | Shares | Sole | 2026-03-04 | |
| 2024-03-31 | $2,252,237 | 5,388 | Shares | Sole | 2026-03-11 | |
| 2023-12-31 | $2,475,111 | 6,083 | Shares | Sole | 2026-03-11 | |
| 2023-09-30 | $723,994 | 2,082 | Shares | Sole | 2026-03-11 | |
| 2023-06-30 | $830,155 | 2,359 | Shares | Sole | 2026-03-11 | |
| 2023-03-31 | $617,222 | 1,959 | Shares | Sole | 2026-03-11 | |
| 2022-12-31 | $781,438 | 2,706 | Shares | Sole | 2026-03-26 | |
| 2022-09-30 | $173,724 | 600 | Call | Sole | 2026-03-26 | |
| 2022-09-30 | $786,680 | 2,717 | Shares | Sole | 2026-03-26 | |
| 2022-06-30 | $338,148 | 1,200 | Call | Sole | 2026-03-26 | |
| 2022-06-30 | $875,521 | 3,107 | Shares | Sole | 2026-03-26 | |
| 2022-03-31 | $1,476,046 | 5,656 | Shares | Sole | 2026-03-26 | |
| 2022-03-31 | $208,776 | 800 | Call | Sole | 2026-03-26 | |
| 2021-12-31 | $43,920 | 200 | Call | Sole | 2026-03-26 | |
| 2021-12-31 | $3,012,912 | 13,720 | Shares | Sole | 2026-03-26 | |
| 2021-09-30 | $7,524,057 | 41,480 | Shares | Sole | 2026-03-26 | |
| 2021-09-30 | $326,502 | 1,800 | Call | Sole | 2026-03-26 | |
| 2021-06-30 | $5,204,876 | 25,814 | Shares | Sole | 2026-03-26 | |
| 2021-03-31 | $4,918,617 | 22,889 | Shares | Sole | 2026-03-26 | |
| 2020-12-31 | $1,959,494 | 8,291 | Shares | Sole | 2026-03-26 | |
| No filing history on record for this holder in this stock. | ||||||